Utilizing vancomycin as secondary prophylaxis for the prevention of recurrent Clostridioides difficile infection

Background: Recurrent Clostridioides difficile infection (CDI) is associated with significant morbidity, mortality, and healthcare-related costs. Although data are minimal, agents including oral vancomycin have been used as secondary prophylaxis to prevent recurrent CDI. Methods: We conducted a rand...

Descripción completa

Detalles Bibliográficos
Autores principales: Kristen, Zeitler, Nguyen, Andrew, Mateja, Candice, Jariwala, Ripal, Bertran-Rodriguez, Carlos, Mayer, Cynthia, Nguyen, Diep, Sampson, Mindy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
C. difficile
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594099/
http://dx.doi.org/10.1017/ash.2023.215

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10594099/
http://dx.doi.org/10.1017/ash.2023.215

Ejemplares similares